diclofenac has been researched along with methyl 5-aminolevulinate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chimenti, S; Colombo, GL; Di Matteo, S; Fargnoli, MC; Frascione, P; Peris, K; Silipo, V | 1 |
| Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
| Gupta, AK; Paquet, M | 1 |
| Calzavara-Pinton, PG; Facchinetti, E; Rossi, MT; Specchia, C; Zane, C | 1 |
| Calzavara-Pinton, P; Pacou, M; Szeimies, RM; Zane, C | 1 |
| Bottoniτ, U; Calvieri, S; Cantisani, C; Cantoresi, F; Didona, D; Losco, L; Mercuri, SR; Moliterni, E; Paolino, G; Scarnò, M; Tallarico, M | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
3 review(s) available for diclofenac and methyl 5-aminolevulinate
| Article | Year |
|---|---|
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Topics: Adjuvants, Immunologic; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Sunlight | 2016 |
2 trial(s) available for diclofenac and methyl 5-aminolevulinate
| Article | Year |
|---|---|
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combinations; Facial Dermatoses; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Quality of Life; Rome; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 2018 |
2 other study(ies) available for diclofenac and methyl 5-aminolevulinate
| Article | Year |
|---|---|
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Decision Trees; Delivery of Health Care; Diclofenac; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic | 2010 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |